Goldman Sachs Keeps On the Sidelines With Intuitive Surgical (ISRG)

Goldman Sachs bumped its price target on Intuitive Surgical (NASDAQ: ISRG) from $466 to $467 but kept its Neutral rating on the shares following Q4 results.

Goldman is remaining on the sidelines with the stock as it sees tailwinds and headwinds as balanced. While the company continues to place systems at a strong rate and has strong adoption in the "other" procedure categories, the company indicated continued weakness in the capex environment. Also, seasonality is increasing, making 4Q numbers a tough comparison heading into 2012. With shares up 63% over the last year, now is not the time to Buy they said.

For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.

Shares of Intuitive Surgical closed at $474.65 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen
• JPMorgan Upgrades TIC Solutions (TIC) to Neutral
• BMO Capital Starts Analog Devices (ADI) at Outperform